Caspase activation and apoptosis in response to proteasome inhibitors. (Q46645046)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Caspase activation and apoptosis in response to proteasome inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Gabriela Paroni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Claudio Brancolini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Henderson CJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Aleo E

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Fontanini A

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

1 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

Cell Death & Differentiation

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

1240-1254

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16094404%20AND%20SRC:MED&resulttype=core&format=json

Activation of apoptosis pathways by anticancer treatment.

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Mechanisms of caspase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Caspase activation: revisiting the induced proximity model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Many cuts to ruin: a comprehensive update of caspase substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Cytochrome C-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

The Bcl-2 family: roles in cell survival and oncogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Mechanisms of cytochrome c release by proapoptotic BCL-2 family members

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

IAP proteins: blocking the road to death's door

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Chemotherapy: targeting the mitochondrial cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Oncogene-dependent apoptosis is mediated by caspase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Requirement for caspase-2 in stress-induced apoptosis before mitochondrial permeabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Apaf1 is required for mitochondrial pathways of apoptosis and brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Proteasome inhibitors: valuable new tools for cell biologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

A mitochondrial perspective on cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Commitment to apoptosis by GD3 ganglioside depends on opening of the mitochondrial permeability transition pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Outer mitochondrial membrane permeabilization during apoptosis triggers caspase-independent mitochondrial and caspase-dependent plasma membrane potential depolarization: a single-cell analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Real-time single cell analysis of Smac/DIABLO release during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2/E3 ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

The membrane-associated inhibitor of apoptosis protein, BRUCE/Apollon, antagonizes both the precursor and mature forms of Smac and caspase-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

A novel ubiquitin fusion system bypasses the mitochondria and generates biologically active Smac/DIABLO

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Structural and biochemical basis of apoptotic activation by Smac/DIABLO

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Structural basis of IAP recognition by Smac/DIABLO

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Caspase activation inhibits proteasome function during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

The proteasome: a novel target for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

The proteasome: a suitable antineoplastic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Proteasome inhibitor-induced apoptosis of glioma cells involves the processing of multiple caspases and cytochrome c release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Conformational change and mitochondrial translocation of Bax accompany proteasome inhibitor-induced apoptosis of chronic lymphocytic leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Regulation of apoptosis proteins in cancer cells by ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Cellular, biochemical, and genetic analysis of mechanism of small molecule IAP inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

Apoptosis and cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

7 January 2021

Differential requirement for caspase 9 in apoptotic pathways in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

7 January 2021

Mitochondrial depolarization accompanies cytochrome c release during apoptosis in PC6 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

7 January 2021

Cellular inhibitor of apoptosis 1 and 2 are ubiquitin ligases for the apoptosis inducer Smac/DIABLO

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

7 January 2021

p53-dependent induction of apoptosis by proteasome inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

7 January 2021

Pro-caspase-3 overexpression sensitises ovarian cancer cells to proteasome inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CDD.4401729

7 January 2021